Taliban gunmen checking mobile phones of Kabul residents
Darpan News Desk IANS, 29 Nov, 2021 12:45 PM
New Delhi, Nov 29 (IANS) Residents of Kabul complain that gunmen linked to the Taliban government have lately been checking their mobile phones, thus violating their privacy, Pajhwok News reported.
Concerned at the unwarranted checks, they said the practice amounts to trampling on human rights and respect for their privacy.
Several individuals from different parts of the capital said that armed men had informed them that their smartphones would be checked, the report said.
A senior government official, however, said the security forces did not have the right to peep into people's mobile phones or harass citizens.
But in some cases, the official believed, intelligence agents might have done so on the basis of tip-offs. He promised an end to the practice.
Bilal Karimi, deputy spokesman for the caretaker government, also acknowledged that the security forces did not have the right to examine mobile phones or harass citizens, the report said.
In some instances, intelligence operatives could have searched the phones of certain suspects on the basis of a tip-off. However, he said, this had not happened to all the citizens.
He added: "Mujahideen of the Islamic Emirate is not doing this; but the name of the Mujahideen may have been misused, and those who face such problems should inform the authorities."
He claimed that many men, who were harassing the people, have been arrested and efforts are being made to crackdown on such imposters.
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.
